Content | Navigation |

School of Pharmacy


Yagna PR Jarajapu, MPharm, PhD,

Associate Professor
16 Sudro Hall

Phone 701.231.8843
Fax 701.231.8333



Pharmacogenomics (PSCI417) and Neuropharmacology (PSCI 416) for Pharm D students.

Research Interests

Targeting Angiotensin Converting Enzyme-2 (ACE2)/Angiotensin-(1-7) System in Bone Marrow-Derived Cells for Vascular Repair in Diabetes.


2002   Ph.D.  Glasgow Caledonian University, UK  
1998   M.Sc.  University of Strathclyde, UK   
1993   M.Pharm. Andhra University, India   
1990   B.Pharm Andhra University, India   

2003 and 2006   ASPET Travel Awards.
2001 British Pharmacological Society Travel Award for Pharmacology-2001, Vancouver, Canada.
2001 European Society for Hypertension Travel Award.
2001 Federation of European Pharmacological Societies (EPHAR) Travel Award.
1997   Academy of Commonwealth Universities (ACU) and Oversees Development Administration (ODA) Shared Scholarship.
1991   University Grants Commission (UGC) Fellowship.
1991   Indian Drug Manufacturers Association (IDMA), G.P.Nair Award.

Professional Appointments

2008-2011  Asst. Instructor, Pharmacology & Therapeutics, University of Florida, Gainesville, FL.
2005-2007  Part-Time, Technology-Scientist, Danish MyoTechnology-USA, Inc. 
2005-2007  Post-Doctoral Associate, Wake Forest University, Winston-Salem NC.
2002-2004  Post-Doctoral Associate, Pharmacology & Therapeutics, University of Florida, Gainesville, FL.
1995-1997  Sr. Pharmacologist, Dr. Reddy’s Research Foundation, Hyderabad, India. 


2011 to date    Member of American Association of Colleges of Pharmacy (AACP).
2007 to date    Professional member of American Heart Association (AHA).
2002 to date    Regular member of American Society of Pharmacology and 
                        Experimental Therapeutics (ASPET).
2006-2011       Member of the Association for Research in Vision and 
                        Ophthalmology (ARVO).
1998-2007       Regular member of the British Pharmacological Society (BPS).
1998-2004       Member of British Physiological Society.
1995-1997       Member of Indian Pharmacological Society (IPS).
Life member    Indian Pharmaceutical Graduates Association (IPGA).

Selected Publications

Jarajapu YP, Bhatwadekar AD, Caballero S, et al. (2013). Activation of the ACE2/Angiotensin-(1-7)/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitor cells. Diabetes. 62(4):1258-69.

Hazra S, Jarajapu YP, Stepps V, et al. (2013). Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model. Diabetologia. 56(3):644-53.

Jarajapu YP, Cai J, Yan Y et al. (2012). Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3. PLoS One. 7(7):e39398.

Jarajapu YP, Grant MB, and Raizada MK. (2012). ACE2/Angiotensin-(1-7)/Mas axis and cardiovascular regeneration. Curr Hypertension Rev. 8:35-46.

Jarajapu YP, Caballero S, Verma A, Nakagawa T, Lo MC, Li Q and Grant MB. (2011). Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells. Invest Ophthalmol Vis Sci. 52(8):5093-104.

Jarajapu YP and Grant MB. (2010). The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res. 106(5):854-69.

Katakam PV, Domoki F, Snipes JA, Busija AR, Jarajapu YP, and Busija DW. (2009). Impaired mitrochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Phsyiol. 296(2):R289-98.

Kielczewski*JL, Jarajapu* YP, McFarland EL, et al. (2009). Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105(9):897-905 (*equal contributions).

Ito I, Jarajapu YP, Grant MB and Knot HJ. (2006). Myogenic tone and reactivity of the rat ophthalmic artery in the acute exposure of high glucose and in a type II diabetic model. Invest Ophthalmol Vis Sci. 47(2):683-92.

Jarajapu YP and Knot HJ. (2005). Relative contribution of protein kinase C and Rho-kinase to myogenic tone in cerebral arteries in hypertension. Am J Physiol Heart Circ Phsyiol. 289(5):H1917-22.

Follow this link for the full list of

Book Chapters

Christ GJ, Burmeister D, Vishwajit S, Jarajapu YP and Andersson K-E. Assessing the performance of tissue-engineered urological implants. In: Densdtedt J and Atala A, editors, Biomaterials and Tissue Engineering in Urology. Cambridge: Woodhead Publishing Limited. 2009:299-315.

Coats P, Jarajapu YP and Hillier C. Differential effects of critical limb ischaemia on endothelium-mediated responses in human resistance arteries. In: Vanhoutte PM, editor, EDHF 2000. London: Taylor and Francis. 2001:376-387.

Professional Services

Invited reviewer for the journals, Cardiovascular Research, Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Pharmacology & Therapeutics.

Grant Reviewer, American Heart Association

Student Focused. Land Grant. Research University.

Follow NDSU
  • Facebook
  • Twitter
  • RSS
  • Google Maps

North Dakota State University
Phone: +1 (701) 231-7456 / Fax: (701) 231-7606
Campus address: Sudro Hall 123
Physical/delivery address: 1401 Albrecht Boulevard, Fargo, ND 58102
Mailing address: NDSU Dept. 2650 / PO Box 6050 / Fargo, ND 58108-6050
Page manager: NDSU School of Pharmacy

Last Updated: Wednesday, May 17, 2017 3:45:38 PM
Privacy Statement